H-E-B plans to offer COVID-19 vaccines once they're available. Photo courtesy of BCM

As a pair of COVID-19 vaccines await emergency-use approval from the U.S. Food and Drug Administration, Texas' largest grocer is prepping for the vaccines' unprecedented rollout.

San Antonio-based H-E-B announced its pharmacies will administer the COVID-19 vaccine to Texans once it's available to the general public.

"At H-E-B, the health and safety of Texans is our top priority," the company noted in a release posted December 3. "As a trusted source for all routine childhood and adult immunizations, H-E-B pharmacies will partner with the federal and state government to administer the COVID-19 vaccine when it becomes available to the general public, following the CDC distribution schedule."

Though it's unclear when H-E-B will receive the vaccine doses and which company's vaccine —Moderna, the Pfizer/BioNTech, or otherwise — will be available through the grocer, health-focused organizations and businesses like H-E-B are preparing for the massive distribution, which could begin as soon as 24 hours after the FDA gives its approval.

The goal of Operation Warp Speed, the federal government's plan to help develop, make, and distribute millions of COVID-19 vaccine doses to Americans, is "to deliver safe vaccines that work, with the first supply becoming available before the end of 2020," according to the Centers for Disease Control and Prevention.

The CDC also notes once a vaccine is approved and released, there may not be enough doses available for all U.S. adults, though supplies will increase over time and "all adults should be able to get vaccinated later in 2021."

The CDC further states that vaccine doses purchased with taxpayer money will be distributed to Americans for free. However, vaccine providers can charge an administration fee for providing the shot.

It's unclear how many doses each store will receive and whether the company plans to distribute the vaccine through its pharmacy drive-thrus, at onsite pop-up medical tents, or solely from its in-store pharmacies.

"We do have all H-E-B pharmacies registered and ready to administer the vaccine," says Leslie Sweet, H-E-B's director of public affairs in the Central Texas region. "We will follow the prescribed allocation schedule as prescribed by [the Department of State Health Services]. We do not yet have a specific date or allocation number to share."

H-E-B pharmacies throughout the state already have some safety measures in place because of COVID-19 concerns, including allowing customers to prepay for prescriptions on the phone prior to picking them up or have their prescriptions delivered for free, and offering no-contact pickup and delivery of prescriptions through its pharmacy drive-thrus.

Additionally, H-E-B says it is continuing to take steps to protect its customers and employees during the pandemic.

"We're going above and beyond our already stringent sanitation standards, cleaning and disinfecting pharmacy counters, waiting areas, and drive-thru surfaces at a higher frequency," the grocer notes in its recent release. "Our pharmacy partners are practicing proper hand-washing throughout the day, and disinfecting and wiping down commonly used surfaces. We've also installed acrylic barriers and provided masks and gloves for all pharmacy partners. … As always, your health and safety is of the utmost importance to us. Together, we can slow the spread."

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston cleantech, space startups named to World Economic Forum cohort

top honor

Two Houston-based startups have been selected to join the World Economic Forum's Technology Pioneers community.

The two-year program aims to help mission-driven, early-stage start-ups scale their innovations through multi-stakeholder initiatives, co-creating partnerships and other gatherings for community members. One-hundred startups are selected each year from around the globe, this year hailing from 23 countries and working in AI, energy, space, biotech markets and more.

Cleantech startup Vaulted Deep was one of 11 energy and climate companies to be named to the cohort. Julia Reichelstein and Omar Abou-Sayed founded the company in 2023. Its technology injects excess organic waste underground to remove carbon dioxide from the atmosphere.

Last year, Vaulted Deep inked a 12-year deal with Microsoft to remove up to 4.9 million metric tons of carbon dioxide from the environment.

The startup has earned several accolades in recent years, including a No. 3 spot on Fast Company’s list of the World’s Most Innovative Companies of 2026. It was also recently named to market intelligence and advisory firm Cleantech Group's annual Global Cleantech 100 list for a second year in a row.

"Waste management is one of the world's great invisible infrastructure systems ... The need for new infrastructure is growing as disposal challenges become more complex and regulations evolve. Vaulted is building the first new disposal pathway for organic waste in decades by putting it deep underground, permanently," the company shared in a LinkedIn post. "This year, we're joining the World Economic Forum's 2026 Tech Pioneers alongside innovators working on the many interconnected challenges shaping our future."

Houston-based Venus Aerospace was also selected to join the cohort, along with six other spacetech companies. The company was founded in 2020 by Sassie and Andrew Duggleby.

The startup specializes in next-generation rocket engine propulsion as a cleaner alternative to traditional combustion engines. The company's rotating detonation rocket engine (RDRE) burns fuel more efficiently and completed a successful high-thrust test flight last year. Venus says it’s the only company in the world that makes a flight-proven, high-thrust RDRE with a “clear path to scaled production.”

"Frontier technologies matter most when they expand what people, industries, and nations can do," Sassie Duggleby, co-founder and CEO of Venus, said in a news release. "For Venus, RDRE does not just represent a more efficient engine. It is a foundation for faster movement, more capable space systems, and new forms of connectivity across the planet. Being named a Technology Pioneer validates the potential of this technology to help shape a future where distance is less limiting."

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston Methodist receives record $110M gift, names future tower

historic gift

Houston Methodist has received the largest gift in the health system's history to establish new funds for neurological, neuroscience, and women’s health research and treatment.

The $110 million gift comes from Houston-based The Brockman Medical Research Foundation, which supports education and research in the science, medicine and healthcare fields. In response, Houston Methodist announced that it will name its forthcoming 26-story hospital facility the Brockman Centennial Tower.

The tower’s entrance will be named the Anna Margaret Bellows Centennial Hall to honor Anna Margaret Bellows, a young camper who died during the Camp Mystic flooding last summer.

“This extraordinary gift accelerates discovery and transforms how care is delivered,” Dr. Marc Boom, president and CEO of Houston Methodist, said in a news release. “We are grateful to The Brockman Medical Research Foundation for its incredible generosity and vision that will help change the lives of generations of patients. Naming Centennial Tower in recognition of this gift reflects the scale of this commitment and its impact on the future of neuroscience, neurological care and women’s health.”

The gift will be divided into two parts:

  • $100 million will go toward creating an innovation fund within the Houston Methodist Academic Institute and the Houston Methodist Neurological Institute
  • $10 million will be devoted to Houston Methodist's Department of Obstetrics and Gynecology

“This tremendous gift will accelerate translational research that broadens our understanding of neurological and other diseases,” Dr. Jenny Chang, president and CEO of the Houston Methodist Academic Institute, added in the release. “It will allow us to leverage state-of-the-art platforms to detect, diagnose and deliver therapeutics, keeping patient care at the center of our mission.”

The Brockman Centennial Tower is expected to open next year in the Texas Medical Center. Spanning more than 1 million square feet, it will house 400 patient beds, an expanded emergency department, new operating rooms and a rooftop garden. It will be connected to Houston Methodist's flagship Paula and Joseph C. “Rusty” Walter III Tower, which opened in 2018. The Centennial Tower was estimated to cost $1.4 billion when announced in 2022.

In addition to the news of the Brockman gift, Houston Methodist also announced this month that it has launched the Houston Methodist Center for Cell and Gene Therapy and tapped an internationally recognized scientist as its leader.

The new center is focused on discovering and developing innovative and cost-effective therapies for a variety of congenital and acquired diseases, including cancer, HIV and cardiovascular disease.

Dr. Malcolm Brenner has been named as the center's inaugural leader and will assume the role starting in October. He will work alongside scientists and support staff from Baylor College of Medicine and Texas Children's Hospital.

Brenner is a professor of pediatrics, medicine, molecular and human genetics and translational biology at Baylor College of Medicine. He is known for making early advances in using bone marrow transplantation as a form of cell therapy and in engineered immune-cell treatments for cancer and infections, according to a release from Houston Methodist.

“Malcolm Brenner is a pioneer in the field of cell and gene therapy and is uniquely qualified to lead Houston Methodist’s research efforts in this field,” Chang added. “His vision and leadership will play a pivotal role in advancing our work in this space.”